Scientists have launched the first clinical trial to test whether an experimental antiviral pill can prevent Bundibugyo Ebola after exposure, offering hope for a new outbreak-control tool.

Two drugs are being trialled in the Ituri region in a programme set up just six weeks after the outbreak was declared, with hopes it will reduce mortality rates

The Democratic Republic of the Congo has launched a record-breaking trial for two drugs, enrolling patients just six weeks after an outbreak was declared in the Ituri region.